Imagine you're a Belgian industrialist with an idea for a device to treat certain cancers. You're convinced it would be a huge improvement over the existing standard. But it would also be hideously expensive, at least initially, and your specialized contraption will provoke cold sweats among your country's public-health accountants. How to convince investors you're not insane?
Read Full Article »
